Product Information
OPTION 2 1.5 MG TABLET is a generic product labeled by L. Perrigo Company, priced at $6.3305 per EA under NDC 00113200312. Its NADAC has been published 523 times since Sep 28, 2016.
FDA first approved this application on Aug 20, 2014.
Strength
1.5 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113200312
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA202334FDA Approved
8/20/2014
On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for OPTION 2 1.5 MG TABLET has been published 523 times since Sep 28, 2016, and over the history we have for it it has declined 73.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3305 per EA |
|---|---|
| All-time high | $23.4877 (Jan 11, 2017) |
| All-time low | $5.2568 (Nov 20, 2024) |
| 52-week high | $6.8109 |
| 52-week low | $6.2162 |
| Median price | $9.3860 |
| Average price | $10.8108 |
| Largest weekly change | +32.8% (Jun 20, 2018) |
| Weeks tracked | 523 |
| Tracking since | Sep 28, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OPTION 2 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OPTION 2 1.5 MG TABLET, manufactured by L. Perrigo Company, is $6.3305 per EA (NDC 00113200312), effective Sep 30, 2026.
How has the price of OPTION 2 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OPTION 2 1.5 MG TABLET has declined 73.0%. It has been tracked across 523 weekly CMS publications since Sep 28, 2016.
What are the highest and lowest recorded NADAC prices for OPTION 2 1.5 MG TABLET?
Since Sep 28, 2016, the NADAC for OPTION 2 1.5 MG TABLET has ranged from a low of $5.2568 (Nov 20, 2024) to a high of $23.4877 (Jan 11, 2017), with a median of $9.3860 per EA.
Are there cheaper alternatives to OPTION 2 1.5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OPTION 2 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OPTION 2 1.5 MG TABLET?
OPTION 2 1.5 MG TABLET (NDC 00113200312) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.